Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Immune Network is Scopus-indexed (Q1, CiteScore 9.3), WoS SCIE. Published by Korean Association of Immunologists.
Checked against the index lists dated .
ISSN 1598-2629Verify ISSN ↗2092-6685Verify ISSN ↗
Publisher: Korean Association of Immunologists
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 34 / 361 | 90th | Q1 |
| Immunology and Allergy | 41 / 234 | 82nd | Q1 |
| Immunology | 48 / 243 | 80th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2016–present, best quartile Q1, CiteScore 9.3.
Immune Network is Q1 in Infectious Diseases (rank 34 of 361), Q1 in Immunology and Allergy (rank 41 of 234) and Q1 in Immunology (rank 48 of 243), by CiteScore 2025.
Immune Network is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.3, which places it in quartile Q1 at the 90th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.729, quartile Q1, with an H-index of 50.
Immune Network is published by Korean Association of Immunologists. Its print ISSN is 1598-2629 and its online ISSN is 2092-6685.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Immune Network has an h-index of 69 and a 2-year mean of 9.23 citations per paper (OpenAlex). Its Scopus CiteScore is 9.3, quartile Q1. On 2-year citations it ranks #13 of 354 Scopus journals in Infectious Diseases.
Immune Network published 44 papers in 2025; its busiest recent year was 2020 with 51. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2024–2026), authors are most often from South Korea (66.3%), China (10.8%) and United States (10.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (2.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.